MedPharm || طبصيدلة
رفتن به کانال در Telegram
شرح مادة الصيدلة السريرية clinical pharmacology 🧑🏻⚕️ معرف التلي: mohammedsalim10 Instagram: _a1mh
نمایش بیشترکشور مشخص نشده استدسته بندی مشخص نشده است
3 508
مشترکین
-324 ساعت
-157 روز
-5830 روز
آرشیو پست ها
3 508
38 years old patient presented with excessive daytime sleepiness (EDS), fatigue, impaired performance, and disturbed nighttime sleep. He was diagnosed with Narcolepsy. Which one of the following is the standard of treatment for EDS?
3 508
Certain conventional treatments for insomnia should be avoided in patients with a history of substance misuse. Which of the following drugs can be best choice for treatment of insomnia in patient with substance abuse?
3 508
Many factors may trigger or induce obstructive sleep apnea (OSA) all listed below, EXCEPT:
3 508
53-year-old man notes fatigue and poor sleep for the past 6 weeks, starting around the time of his father's death. What is the type of insomnia this patient have?
3 508
63 years old man with narcolepsy type 1, he has a history of disc prolapse on tramadol and benign prostatic hyperplasia (BPH) on tamsulosin. What is the safest treatment for cataplexy for this patient?
3 508
DP is a 46-year-old woman who presents with a complaint of difficulty initiating sleep. After a careful sleep history, you rule out other potential sleep disorders and want to start her on drug therapy for her insomnia. Which of the following would be the best recommendation
3 508
An elderly patient who has difficulty in sleep with frequent nighttime awakenings.
What is the best treatment for this patient ?
3 508
M is 38 years old patient presented to the sleep hygienist with excessive day time sleepiness (EDS), sleep attacks that last up to 30 minutes, fatigue, impaired performance, and disturbed nighttime sleep. He was diagnosed with Narcolepsy. Which one of the following is the standard of treatment of EDS?
3 508
AK. is 66 years old male patient with history of depression, arrhythmia, and substance abuse. What is the best treatment for treating insomnia for this patient?
3 508
Obstructive sleep apnea (OSA) is potentially life-threatening and characterized by repeated episodes of nocturnal breathing cessation followed by blood oxygen desaturation. Which one of the following drugs are approved by the FDA to improve wakefulness in those with residual daytime sleepiness. They should be used only in patients without cardiovascular disease who are using optimal PAP therapy.
3 508
Concerning the pharmacological therapy of non-cognitive symptoms of AD, all of the following treatments are correct EXCEPT:
3 508
Selective serotonin reuptake inhibitors (SSRIs) are often prescribed for those with Alzheimer's disease, with best evidence is for sertraline and citalopram. SSRIs are usually given to Alzheimer Disease patients to control;
3 508
At which stage of Alzheimer disease does a 63-year-old female with MMSE of 17 have?
3 508
17-Change or discontinuation of cholinesterase inhibitor therapy AD is indicated in all of the following cases EXCEPT:
